
Cardiometabolic Morbidity and Other Prognostic Factors for Mortality in Adult Hospitalized COVID-19 Patients in North Jakarta, Indonesia
References
- Dong E, Du H, Gardner L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis. 2020; 20(5): 533–4. DOI: 10.1016/S1473-3099(20)30120-1
- Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: Summary of a Report of 72314 Cases From th eChinese Center for Disease Control and Prevention. JAMA. 2020; 323(13): 1239–42. DOI: 10.1001/jama.2020.2648
- Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. Lancet. 2020; 395(10229): 1054–62. DOI: 10.1016/S0140-6736(20)30566-3
- Chen TL, Dai Z, Mo P, et al. Clinical Characteristics and Outcomes of Older Patients with Coronavirus Disease 2019 (COVID-19) in Wuhan, China: A Single-Centered, Retrospective Study. J Gerontol A Biol Sci Med Sci. 2020; 75(9): 1788–95. DOI: 10.1093/gerona/glaa089
- Zhang J, Wang X, Jia X, et al. Risk factors for disease severity, unimprovement, and mortality in COVID-19 patients in Wuhan, China. Clin Microbiol Infect. 2020; 26(6): 767–72. DOI: 10.1016/j.cmi.2020.04.012
- Li X, Xu S, Yu M, et al. Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. J Allergy Clin Immunol. 2020; 146(1): 110–8. DOI: 10.1016/j.jaci.2020.04.006
- Phua J, Faruq MO, Kulkarni AP, et al. Critical care bed capacity in Asian countries and regions. Crit Care Med. 2020; 48(5): 654–62. DOI: 10.1097/CCM.0000000000004222
- Sethuraman N, Jeremiah SS, Ryo A. Interpreting Diagnostic Tests for SARS-CoV-2. JAMA – J Am Med Assoc. 2020; 323(22): 2249–51. DOI: 10.1001/jama.2020.8259
- Burhan E, Syam AF, Rahyussalim AJ, et al. The emergence of COVID-19 in Indonesia: Analysis of predictors of infection and mortality using independent and clustered data approaches. medRxiv; 2020. DOI: 10.1101/2020.07.10.20147942
- WHO/IASO/IOTF. The Asia-Pacific perspective: Redefining obesity and its treatment. Melbourne: Health Communications Australia; 2000.
- Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 Report. JAMA. 2003; 289: 2560–72. DOI: 10.1001/jama.289.19.2560
- Liu J, Liu Y, Xiang P, et al. Neutrophil-to-lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in the early stage. J Transl Med. 2020; 18(1): 1–12. DOI: 10.1186/s12967-020-02374-0
- Wagner J, DuPont A, Larson S, Cash B, Farooq A. Absolute lymphocyte count is a prognostic marker in Covid-19: A retrospective cohort review. Int J Lab Hematol. 2020; 42(6): 761–5. DOI: 10.1111/ijlh.13288
- Guan W, Ni Z, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020; 382(18): 1708–20. DOI: 10.1056/NEJMoa2002032
- World Health Organization Indonesia. Coronavirus Disease 2019 (COVID-19) Situation Report 43 [Internet]. 2021. Retrieved from:
https://cdn.who.int/media/docs/default-source/searo/indonesia/covid19/external-situation-report-43_17-february.pdf?sfvrsn=1889cdf9_5 (accessed 23 February 2021). - Widarta S. (ed.) Indeks Pembangunan Manusia DKI Jakarta 2020. Jakarta: Badan Pusat Statistik Provinsi DKI Jakarta; 2020.
- Richardson S, Hirsch JS, Narasimhan M, et al. Presenting Characteristics, Comorbidities, and Outcomes among 5700 Patients Hospitalized with COVID-19 in the New York City Area. JAMA – J Am Med Assoc. 2020; 323(20): 2052–9. DOI: 10.1001/jama.2020.6775
- Svensson P, Hofmann R, Häbel H, Jernberg T, Nordberg P. Association between cardiometabolic disease and severe COVID-19: A nationwide case-control study of patients requiring invasive mechanical ventilation. BMJ Open. 2021; 11(2): 1–10. DOI: 10.1136/bmjopen-2020-044486
- O’hearn M, Liu J, Cudhea F, Micha R, Mozaffarian D. Coronavirus disease 2019 hospitalizations attributable to cardiometabolic conditions in the united states: A comparative risk assessment analysis. J Am Heart Assoc. 2021; 10(5): 1–27. DOI: 10.1161/JAHA.120.019259
- De Almeida-Pititto B, Dualib PM, Zajdenverg L, et al. Severity and mortality of COVID 19 in patients with diabetes, hypertension and cardiovascular disease: A meta-analysis. Diabetol Metab Syndr [Internet]. 2020; 12(1): 1–12. DOI: 10.1186/s13098-020-00586-4
- Geerlings SE, Hoepelman AIM. Immune dysfunction in patients with diabetes mellitus (DM). FEMS Immunol Med Microbiol. 1999; 26(3–4): 259–65. DOI: 10.1111/j.1574-695X.1999.tb01397.x
- Andersen CJ, Murphy KE, Fernandez ML. Impact of obesity and metabolic syndrome on immunity. Adv Nutr. 2016; 7(1): 66–75. DOI: 10.3945/an.115.010207
- Singh MV, Chapleau MW, Harwani SC, Abboud FM. The immune system and hypertension. Immunol Res. 2014; 59(1–3): 243–53. DOI: 10.1007/s12026-014-8548-6
- Sharifi Y, Payab M, Mohammadi-Vajari E, et al. Association between cardiometabolic risk factors and COVID-19 susceptibility, severity and mortality: A review. J Diabetes Metab Disord. 2021; (0123456789). DOI: 10.1007/s40200-021-00822-2
- Gupta A, Madhavan MV, Sehgal K, et al. Extrapulmonary manifestations of COVID-19. Nat Med. 2020; 26(7): 1017–32. DOI: 10.1038/s41591-020-0968-3
- Lillicrap D. Disseminated intravascular coagulation in patients with 2019-nCoV pneumonia. J Thromb Haemost. 2020; 18(4): 786–7. DOI: 10.1111/jth.14781
- Paz LO, Capodanno D, Montalescot G, Angiolillo DJ. Coronavirus Disease 2019 – associated thrombosis and coagulopathy: Review of the pathophysiological characteristics and implications for antithrombotic management. J Am Hear Assoc. 2021; 10:
e019650 . DOI: 10.1161/JAHA.120.019650 - Terpos E, Ntanasis-Stathopoulos I, Elalamy I, et al. Hematological findings and complications of COVID-19. Am J Hematol. 2020; 95(7): 834–47. DOI: 10.1002/ajh.25829
- Bonnet N, Martin O, Boubaya M, et al. High flow nasal oxygen therapy to avoid invasive mechanical ventilation in SARS-CoV-2 pneumonia: A retrospective study. Ann Intensive Care. 2021; 11(1): 1–9. DOI: 10.1186/s13613-021-00825-5
- King CS, Sahjwani D, Brown AW, et al. Outcomes of mechanically ventilated patients with COVID-19 associated respiratory failure. PLoS One. 11 November 2020; 15: 1–9. DOI: 10.1371/journal.pone.0242651
- Bahl A, Van Baalen MN, Ortiz L, et al. Early predictors of in-hospital mortality in patients with COVID-19 in a large American cohort. Intern Emerg Med. 2020; 15(8): 1485–99. DOI: 10.1007/s11739-020-02509-7
- Oliveira E, Parikh A, Lopez-Ruiz A, et al. ICU outcomes and survival in patients with severe COVID-19 in the largest health care system in central Florida. PLoS One. 3 March 2021; 16: 1–14.DOI: 10.1371/journal.pone.0249038
- Eltzschig HK, Carmeliet P. Hypoxia and inflammation. N Engl J Med. 2011; 364(7): 656–65. DOI: 10.1056/NEJMra0910283
- Mejía F, Medina C, Cornejo E, et al. Oxygen saturation as a predictor of mortality in hospitalized adult patients with COVID-19 in a public hospital in Lima, Peru. PLoS One. 2020; 15(12): 1–12. DOI: 10.1371/journal.pone.0244171
- Zhang L, Yu CH, Guo KP, Huang CZ, Mo LY. Prognostic role of red blood cell distribution width in patients with sepsis: A systematic review and meta-analysis. BMC Immunol. 2020; 21(1): 1–8. DOI: 10.1186/s12865-020-00369-6
- Foy BH, Carlson JCT, Reinertsen E, et al. Association of red blood cell distribution width with mortality risk in hospitalized adults with SARS-CoV-2 infection. JAMA Netw Open. 2020; 3(9): 1–13. DOI: 10.1001/jamanetworkopen.2020.22058
- Karampitsakos T, Akinosoglou K, Papaioannou O, et al. Increased red cell distribution width Is associated with disease severity in hospitalized adults with SARS-CoV-2 Infection: An observational multicentric study. Front Med. 2020 December; 7: 3–6. DOI: 10.3389/fmed.2020.616292
- Soni M, Gopalakrishnan R. Significance of RDW in predicting mortality in COVID-19—An analysis of 622 cases. Int J Lab Hematol. 2021 March; 1–3. DOI: 10.1111/ijlh.13526
- Henry BM, Benoit JL, Benoit S, et al. Red blood cell distribution width (RDW) predicts COVID-19 severity: A prospective, observational study from the Cincinnati SARS-CoV-2 Emergency Department cohort. Diagnostics. 2020; 10(9): 1–9. DOI: 10.3390/diagnostics10090618
- Tan L, Wang Q, Zhang D, et al. Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study. Signal Transduct Target Ther. 2020; 5: 33. DOI: 10.1038/s41392-020-0148-4
- Zhao Q, Meng M, Kumar R, Wu Y, Huang J. Lymphopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A systemic review and meta-analysis. Int J Infect Dis. 2020; 96: 131–5. DOI: 10.1016/j.ijid.2020.04.086
- Fathi N, Rezaei N. Lymphopenia in COVID-19: Therapeutic opportunities. Cell Biol Int. 2020; 44(9): 1792–7. DOI: 10.1002/cbin.11403
- Sanders JM, Monogue ML, Jodlowski TZ, Cutrell JB. Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review. JAMA – J Am Med Assoc. 2020; 323(18): 1824–36. DOI: 10.1001/jama.2020.6019
- Wang M, Cao R, Zhang L, et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 2020; 30(3): 269–71. DOI: 10.1038/s41422-020-0282-0
- Gao J, Tian Z, Yang X. Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. Biosci Trends. 2020; 14(1): 1–2. DOI: 10.5582/bst.2020.01047
- Geleris J, Sun Y, Platt J, et al. Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19. N Engl J Med. 2020; 382(25): 2411–8. DOI: 10.1056/NEJMoa2012410
- Rosenberg ES, Dufort EM, Udo T, et al. Association of Treatment with Hydroxychloroquine or Azithromycin with In-Hospital Mortality in Patients with COVID-19 in New York State. JAMA – J Am Med Assoc. 2020; 323(24): 2493–502. DOI: 10.1001/jama.2020.8630
- Arshad S, Kilgore P, Chaudhry ZS, et al. Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19. Int J Infect Dis. 2020; 97: 396–403. DOI: 10.1016/j.ijid.2020.06.099
- The RECOVERY Collaborative Group. Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report. N Engl J Med. 2020; 1–11.
- Mahévas M, Tran VT, Roumier M, et al. Clinical efficacy of hydroxychloroquine in patients with covid-19 pneumonia who require oxygen: Observational comparative study using routine care data. BMJ. 2020; 369: m1884.
- The RECOVERY Collaborative Group. Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19. N Engl J Med. 2020; 383(21): 2030–40. DOI: 10.1056/NEJMoa2022926
- Cavalcanti AB, Zampieri FG, Rosa RG, et al. Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19. N Engl J Med. 2020; 383(21): 2041–52. DOI: 10.1056/NEJMoa2019014
- Borba MGS, Val FFA, Sampaio VS, et al. Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: A Randomized Clinical Trial. JAMA Netw Open. 2020; 3(4.23):
e208857 . DOI: 10.1001/jamanetworkopen.2020.8857
DOI: https://doi.org/10.5334/gh.1019 | Journal eISSN: 2211-8179
Language: English
Submitted on: Feb 28, 2021
Accepted on: Jan 24, 2022
Published on: Feb 18, 2022
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
© 2022 Arvin Pramudita, Siti Rosidah, Novi Yudia, Jeffri Simatupang, Wulan Pingkan Sigit, Rita Novariani, Priscilia Myriarda, Bambang Budi Siswanto, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.